•
Mar 31, 2024

AMN Healthcare Q1 2024 Earnings Report

AMN Healthcare's Q1 2024 performance was marked by a revenue decrease of 27% year-over-year, alongside a decline in net income and adjusted EPS, reflecting weaker demand in nurse staffing offset by healthy trends in other key businesses.

Key Takeaways

AMN Healthcare reported a Q1 2024 revenue of $821 million, a 27% decrease year-over-year. GAAP EPS was $0.45, and adjusted EPS was $0.97. The company is managing expenses and capital spending amidst lower travel nurse demand while focusing on long-term objectives.

Consolidated revenue for the quarter was $821 million, a 27% decrease from the prior year.

Net income was $17 million, or $0.45 per diluted share, compared to $84 million, or $2.02 per diluted share, in the first quarter of 2023.

Adjusted diluted EPS in the first quarter was $0.97 compared with $2.49 in the same quarter a year ago.

Revenue for the Nurse and Allied Solutions segment was $519 million, lower by 37% year over year.

Total Revenue
$821M
Previous year: $1.13B
-27.1%
EPS
$0.97
Previous year: $2.49
-61.0%
Gross Profit
$258M
Previous year: $369M
-30.1%
Cash and Equivalents
$51M
Previous year: $29M
+75.9%
Free Cash Flow
$63.2M
Previous year: $25.9M
+143.7%
Total Assets
$2.87B
Previous year: $2.88B
-0.3%

AMN Healthcare

AMN Healthcare

AMN Healthcare Revenue by Segment

Forward Guidance

Revenue in the second quarter of 2024 is expected to be 24-26% lower than prior year and 9-11% lower sequentially.